Dr. Guy Sauvageau’ team from the Institute for Research in Immunology and Cancer (IRIC) achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs.

In a recent study published in Nature Methods, the scientists describe how they succeeded in identifying two new chemical compounds that allow to maintain leukemic stem cells in culture when these are grown outside the body.

This important advance opens the way to the identification of new cancer drugs to fight acute myeloid leukemia, one of the most aggressive forms of blood cancer.

This research project was financed by Génome Québec and Genome Canada as part of the Genomics and Personalized Health Competition.

Innovative chemo-genomic tools to improve clinical outcome in acute myeloid leukemia

Read the press release